Will the world soon witness a breakthrough against one of the deadliest forms of breast cancer? Ongoing scientific research suggests that possibility may not be entirely out of reach. A growing field known as apitherapy the use of bee-derived substances for medical purposes is drawing renewed attention from researchers worldwide.
A landmark study led by Ciara Duffy and published in npj Precision Oncology examined how honeybee venom affects some of the most aggressive breast cancer types, including triple-negative and HER2-enriched cancers.
The researchers found that melittin, the main active component in bee venom, can rapidly destroy cancer cells by attacking their outer membranes. In controlled laboratory experiments, the compound was shown to induce cell death and disrupt critical growth signals used by cancer cells to survive and multiply.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment